SPOTLIGHT -
Pharmaceutical Executive
Effective DTC Product Web Sites Must Synthesize Advertising and Labeling Requirements
Lunit Expands AI Cancer Screening to France and Portugal
The company’s software will be used to help with chest and breast cancer screenings.
Gen-Z Influence on Pharma M&A
Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.
FDA’s Oncologic Drugs Advisory Committee Recommends Earlier Treatment with Carvykti for Relapsed or Refractory Multiple Myeloma
In a unanimous decision, the committee recommended Carvykti based on promising data from the Phase III CARTITUDE-4 study, which showed a positive risk-benefit assessment.
Recent Licensing Agreement Poised to Advance Company ADC
In an interview with PharmExec Associate Editor Don Tracy, Jingsong Wang discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033.
Precision Medicine: Investments and Outcomes Expected
Precision medicine is now seen as a healthcare approach for both the present and the future, particularly with the explosion of personalized care delivery.
New Report Shows AI Improved Treatments for Biofilm Infections
The technology was used to develop new peptides.